Table Of Contents

1. Introduction 68
1.1. Objectives Of The Study 68
1.2. Market Definition 68
1.3. Overview Of North America Bio-Implants Market 68
1.4. Currency And Pricing 70
1.5. Limitation 70
1.6. Markets Covered 71
2. Market Segmentation 75
2.1. Markets Covered 75
2.2. Geographic Scope 76
2.3. Years Considered For The Study 77
2.4. Currency And Pricing 77
2.5. Research Methodology 78
2.6. Primary Interviews With Key Opinion Leaders 81
2.7. Secondary Sources 82
2.8. Assumptions 82
3. Market Overview 83
3.1. Drivers 85
3.1.1. Rising Number Of Aging And Geriatric Population 85
3.1.2. Changing Lifestyle Problems 85
3.1.3. Rising Incidence Of Chronic Diseases 86
3.1.4. Increasing Awareness About Cosmetic Implants 87
3.1.5. Technological Advancement In Implants 88
3.1.6. Rising Demand For Non-Surgical Bio-Implants 88
?
3.2. Restraints 89
3.2.1. High Cost Of Implants 89
3.2.2. Regulatory Scenario 89
3.2.3. Unfavourable Reimbursement Policies 90
3.3. Opportunities 91
3.3.1. Emerging Inclination For Mis Surgeries 91
3.3.2. Growing Number Of Diagnostic Centers And Clinics 92
3.3.3. Emerging Countries 92
3.3.4. Rising Medical Tourism 93
3.4. Challenges 94
3.4.1. Side-Effects Of Various Cosmetic Surgery 94
3.4.2. Lack Of Trained Professionals 94
4. Executive Summary 95
5. Premium Insights 99
6. North America Bio-Implants Market, By Product Type 101
6.1. Overview 102
6.2. Orthopedics & Trauma 104
6.2.1. Reconstructive Joint Replacements 106
6.2.1.1. Knee Replacement Implants 106
6.2.1.2. Hip Replacement Implants 106
6.2.1.3. Extremities 107
6.2.2. Orthobiologics 109
6.2.2.1. Hyaluronic Acid 109
6.2.2.2. Bone Substitutes 110
6.2.2.3. Bone Growth Factors 110
6.2.2.4. Tissue Implants 110
6.2.2.5. Bone Cement 110
?
6.2.3. Trauma Implants 111
6.2.3.1. Internal Trauma Fixation Devices 111
6.2.3.2. Craniomaxillofacial Fixation Devices 111
6.2.3.3. Implantable Trauma Stimulators 112
6.2.4. Sports Medicine 112
6.3. Pacing Devices 112
6.3.1. Cardiac Resynchronization Therapy Devices (Crtd) 113
6.3.2. Implantable Cardioverter Defibrillators (Icd) 114
6.3.3. Implantable Cardiac Pacemakers (Icp) 114
6.3.3.1. Single Chambered 115
6.3.3.2. Dual Chambered 115
6.3.3.3. Multiple Chambered 115
6.3.4. Pacing Accessories 115
6.3.4.1. Pacing Leads 116
6.3.4.2. Pacing Batteries 116
6.4. Stents & Related Implants 116
6.4.1. Coronary Stents 118
6.4.1.1. Drug-Eluting Stents 118
6.4.1.2. Bare-Metal Coronary Stents 119
6.4.1.3. Bioabsorbable Stents 119
6.4.2. Peripheral Stents 119
6.4.2.1. Endovascular Stent-Grafts 120
6.4.2.2. Renal & Related Stents 120
6.4.2.3. Femoral & Related Stents 120
6.4.2.4. Carotid Stents 120
6.4.3. Stent-Related Implants 121
6.4.3.1. Synthetic Grafts 121
6.4.3.2. Vascular Grafts 122
6.4.3.3. Peripheral Grafts 122
6.4.3.4. Vena Cava Filters 122
6.5. Spinal Implants 123
6.5.1. Thoracolumbar Implants 124
6.5.2. Intervertebral Spacers 124
6.5.3. Machined Allograft Spacers 125
6.5.4. Cervical Implants 125
6.5.5. Motion Preservation Implants 125
6.5.6. Implantable Spinal Stimulators 125
6.6. Ophthalmic Implants 125
6.6.1. Intraocular Lens 127
6.6.2. Glaucoma & Other Lenses 127
6.7. Structural Cardiac Implants 127
6.7.1. Heart Valves & Accessories 129
6.7.2. Tissue Heart Valves 129
6.7.3. Mechanical Heart Valves 129
6.7.4. Heart Valve Repair Devices 129
6.7.5. Ventricular Assist Device (Vad) 129
6.7.6. Implantable Heart Monitors 130
6.7.7. Insertable Loop Recorders (Ilrs) 130
6.7.8. Implantable Hemodynamic Monitors (Ihm) 130
6.8. Dental Implants 131
6.8.1. Plate Form Dental Implants 132
6.8.2. Root Form Dental Implants 132
6.9. Neurostimulators Implants 133
6.9.1. Cortical Stimulators 134
6.9.2. Deep Brain Stimulators 134
6.9.3. Sacral Nerve Stimulators 134
6.9.4. Spinal Cord Stimulators 135
6.9.5. Vagus Nerve Stimulators 135
6.10. Prosthetic Implants 135
6.10.1. Osseointegration 136
6.10.2. Titanium-Based Prosthetic Implants 136
6.11. Others 137
6.11.1. Gynecological Devices 138
6.11.2. Drug Implants 138
6.11.3. Cosmetic Implants 139
6.11.4. Gastroenterological Implants 139
6.11.5. Urological Implants 139
6.11.6. Skin & Wound Care 139
6.11.7. Otolaryngeal Implants 139
7. North America Bio-Implants Market, By Type 140
7.1. Overview 141
7.2. Allograft 143
7.3. Autograft 144
7.4. Xenograft 145
7.5. Synthetic 146
7.6. Others 147
8. North America Bio-Implants Market, By Material 148
8.1. Overview 149
8.2. Biomaterial Metal 151
8.2.1. Titanium 152
8.2.2. Gold 152
8.2.3. Silver 152
8.2.4. Platinum 153
8.3. Alloy 153
?
8.4. Polymer 154
8.4.1. Natural Polymers 155
8.4.2. Synthetic Polymers 155
8.5. Ceramics 156
8.6. Acrylic Hydrogel 157
9. North America Bio-Implants Market, Mode Of Administration 158
9.1. Overview 159
9.2. Surgical 161
9.3. Non-Surgical 162
9.3.1. Injectable Fillers/Biomaterials 163
9.3.2. Osteogenic Injectable Bone Substitutes 163
9.3.3. Viscosupplementation 164
9.3.4. Viscoaugmentation 164
10. North America Bio-Implants Market, By End-User 165
10.1. Overview 166
10.2. Clinics 168
10.3. Hospitals 169
10.4. Ambulatory Surgical Centers 170
10.5. Others 171
11. North America Bio-Implants Market, By Geography 172
11.1. North America 173
11.1.1. U.S. 195
11.1.2. Canada 210
11.1.3. Mexico 225
12. North America Bio-Implants Market, Company Landscape 240
12.1. Company Share Analysis; North America 240
?
13. Company Profiles 241
13.1. Medtronic 241
13.1.1. Company Overview 241
13.1.2. Revenue Analysis 242
13.1.3. Product Portfolio 243
13.1.4. Recent Developments 244
13.2. Johnson & Johnson Services, Inc. 245
13.2.1. Company Overview 245
13.2.2. Johnson & Johnson Services, Inc.; Revenue Analysis 245
13.2.3. Product Portfolio 246
13.2.4. Recent Developments 246
13.3. Edward Lifesciences Corporation 247
13.3.1. Company Overview 247
13.3.2. Edward Lifesciences Corporation ;Revenue Analysis 247
13.3.3. Product Portfolio 248
13.3.4. Recent Developments 248
13.4. Boston Scientific Corporation 249
13.4.1. Company Overview 249
13.4.2. Boston Scientific Corporation; Revenue Analysis 249
13.4.3. Product Portfolio 250
13.4.4. Recent Developments 250
13.5. Integra Lifesciences Corporation 251
13.5.1. Company Overview 251
13.5.2. Integra Lifesciences Corporation ;Revenue Analysis 251
13.5.3. Product Portfolio 252
13.5.4. Recent Developments 252
13.6. Abbott 253
13.6.1. Company Overview 253
13.6.2. Abbott ;Revenue Analysis 253
13.6.3. Product Portfolio 254
13.6.4. Recent Developments 254
13.7. C. R. Bard, Inc. 255
13.7.1. Company Overview 255
13.7.2. C. R. Bard, Inc.;Revenue Analysis 255
13.7.3. Product Portfolio 256
13.7.4. Recent Developments 256
13.8. Zimmer Biomet 257
13.8.1. Company Overview 257
13.8.2. Zimmer Biomet ;Revenue Analysis 257
13.8.3. Product Portfolio 258
13.8.4. Recent Developments 258
13.9. Biotronik Se & Co. Kg 259
13.9.1. Company Overview 259
13.9.2. Biotronik Se & Co. Kg ;Company Snapshot 259
13.9.3. Product Portfolio 260
13.9.4. Recent Developments 260
13.10. Lifenet Health, Inc. 261
13.10.1. Company Overview 261
13.10.2. Lifenet Health, Inc.;Company Snapshot 261
13.10.3. Product Portfolio 262
13.10.4. Recent Developments 262
13.11. Integrated Orbital Implants 263
13.11.1. Company Overview 263
13.11.2. Integrated Orbital Implants ;Company Snapshot 263
13.11.3. Product Portfolio 264
13.11.4. Recent Developments 264
?
13.12. Smith & Nephew 265
13.12.1. Company Overview 265
13.12.2. Smith & Nephew ;Revenue Analysis 265
13.12.3. Product Portfolio 266
13.12.4. Recent Developments 267
13.13. Stryker 268
13.13.1. Company Overview 268
13.13.2. Stryker ;Revenue Analysis 268
13.13.3. Product Portfolio 269
13.13.4. Recent Developments 269
13.14. W. L. Gore & Associates, Inc 270
13.14.1. Company Overview 270
13.14.2. W. L. Gore & Associates, Inc ;Company Snapshot 270
13.14.3. Product Portfolio 271
13.14.4. Recent Developments 271
13.15. Valeant Pharmaceuticals International Inc. 272
13.15.1. Company Overview 272
13.15.2. Valeant Pharmaceuticals International Inc.;Revenue Analysis 272
13.15.3. Product Portfolio 273
13.15.4. Recent Developments 273
13.16. Somnomed 274
13.16.1. Company Overview 274
13.16.2. Somnomed ;Revenue Analysis 274
13.16.3. Product Portfolio 275
13.16.4. Recent Developments 275
13.17. Wright Medical Group N.V. 276
13.17.1. Company Overview 276
13.17.2. Wright Medical Group N.V.;Revenue Analysis 276
13.17.3. Product Portfolio 277
13.17.4. Recent Developments 277
13.18. Livanova Plc 278
13.18.1. Company Overview 278
13.18.2. Livanova Plc ;Revenue Analysis 278
13.18.3. Product Portfolio 279
13.18.4. Recent Developments 279
13.19. St. Jude Medical, Inc. (A Subsidiary Of Abbott) 280
13.19.1. Company Overview 280
13.19.2. St. Jude Medical, Inc.;Company Snapshot 280
13.19.3. Product Portfolio 281
13.19.4. Recent Developments 281
13.20. Mimedx Group, Inc. 282
13.20.1. Company Overview 282
13.20.2. Mimedx Group, Inc.;Revenue Analysis 282
13.20.3. Product Portfolio 283
13.20.4. Recent Developments 283
13.21. Cook Group 284
13.21.1. Company Overview 284
13.21.2. Cook Group ;Company Snapshot 284
13.21.3. Product Portfolio 284
13.21.4. Recent Developments 284
14. Related Reports 285